T. Watkins-Riedel

发表

Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis.

P. Ferenci, M. Gschwantler, P. Steindl‐Munda, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial

C. Datz, R. Stauber, P. Ferenci, 2001 .

Development of a fully automated high throughput PCR for the detection of SARS-CoV-2: The need for speed

O. Landt, V. Corman, F. Ratzinger, 2020, Virulence.

Detection of hepatitis C virus (HCV) RNA in normal cervical smears of HCV-seropositive patients.

G. Hudelist, M. Manavi, K. Pischinger, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Very Early Viral Kinetics on Interferon Treatment in Chronic Hepatitis C virus Genotype 4 Infection

P. Ferenci, F. Wrba, M. Gschwantler, 2008, Antiviral Therapy.

Very early viral kinetics on interferon treatment in chronic hepatitis C virus genotype 4 infection.

F. Wrba, P. Ferenci, M. Gschwantler, 2008, Antiviral therapy.

Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study

P. Ferenci, A. Gangl, F. Wrba, 2001, The Lancet.

Comparison of SeroMP IgA with four other commercial assays for serodiagnosis of Mycoplasma pneumoniae pneumonia.

G. Stanek, F. Daxböck, T. Watkins-Riedel, 2001, Diagnostic microbiology and infectious disease.

CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR

W. Rabitsch, H. Greinix, F. Keil, 2001, Bone Marrow Transplantation.

Performance Evaluation of the Fully Automated NeuMoDx RT-PCR Platform for the Quantification of CMV and EBV DNA in EDTA Plasma: Implications for Clinical Management and Establishment of a Conversion Formula

A. N. Herdina, F. Ratzinger, M. Breuer, 2022, Microbiology spectrum.

Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load

E. Penner, P. Ferenci, A. Gangl, 2003, Hepatology.

Evidence of hepatitis C virus in cervical smears.

E. Kucera, M. Manavi, K. Czerwenka, 1999, The Journal of infection.

Rapid diagnosis of enterovirus infections by real-time PCR on the LightCycler using the TaqMan format.

P. Hufnagl, D. Hollemann, T. Watkins-Riedel, 2002, Diagnostic microbiology and infectious disease.

Comparison of the Bayer VERSANT HCV RNA 3.0 and the Roche COBAS Amplicor HCV Monitor, Version 2.0, assays in HCV genotype 4 infection

P. Ferenci, M. Gschwantler, W. Jessner, 2007, Journal of viral hepatitis.

Early viral kinetics on treatment with pegylated interferon‐α‐2a in chronic hepatitis C virus genotype 1 infection *

C. Datz, R. Stauber, P. Ferenci, 2003, Journal of viral hepatitis.

Persistently elevated IgA antibodies to Mycoplasma pneumoniae in patients with internal carotid artery stenosis

A. Assadian, O. Assadian, T. Watkins-Riedel, 2011, GMS Krankenhaushygiene interdisziplinar.

Hepatitis C viral dynamics: basic concept and clinical significance.

P. Ferenci, W. Jessner, P. Steindl‐Munda, 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Interim analysis of a randomized controlled trial of combination of ribavirin and high dose interferon‐α in interferon nonresponders with chronic hepatitis C

C. Datz, R. Stauber, P. Ferenci, 1999, Journal of viral hepatitis.

Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.

E. Kubista, C. Singer, G. Hudelist, 2004, Gynecologic oncology.

Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial. Austrian Hepatitis Study Group.

C. Datz, R. Stauber, P. Ferenci, 2001, European journal of gastroenterology & hepatology.

LONG-TERM ORAL GANCICLOVIR PROPHYLAXIS FOR PREVENTION OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN CYTOMEGALOVIRUS HIGH-RISK RENAL TRANSPLANT RECIPIENTS

J. Kletzmayr, R. Klauser, T. Watkins-Riedel, 2000, Transplantation.

Lack of impact of ABO blood group or corresponding isoantibodies on the immune response after rabies vaccination

G. Heinze, C. Buchta, P. Höcker, 2005, Wiener klinische Wochenschrift.

Hemodialysis access surgery--is there an increased risk of acquiring hepatitis C virus compared to other elective vascular interventions?

A. Assadian, O. Assadian, G. Hagmüller, 2008, VASA. Zeitschrift fur Gefasskrankheiten.